Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Journal of the Neurological Sciences|February 12, 1997
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of NeurologyP Trouillas, T Takayanagi, M Hallett, et al.
Cerebellum (London, England)|October 24, 2012
Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrumentH Jacobi, M Rakowicz, R Rola, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2003
PARK6 is a common cause of familial parkinsonismE M Valente, F Brancati, V Caputo, et al.
Neurology|January 28, 2004
Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosumC Casali, E M Valente, E Bertini, et al.
Annals of Neurology|February 16, 1999
Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotesM Cossée, A Dürr, M Schmitt, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2015
Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT₁ F receptor agonists: Evolution from bicyclic to monocyclic coresDeyi Zhang, Maria-Jesus Blanco, Bai-Ping Ying, et al.
Neurology|February 24, 2010
Responsiveness of different rating instruments in spinocerebellar ataxia patientsT Schmitz-Hübsch, R Fimmers, M Rakowicz, et al.
Neurology|August 13, 2008
SCA Functional Index: a useful compound performance measure for spinocerebellar ataxiaT Schmitz-Hübsch, P Giunti, D A Stephenson, et al.
Human Molecular Genetics|March 11, 1999
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's DiseaseN Abbas, C B Lücking, S Ricard, et al.
Journal of Medicinal Chemistry|February 17, 2022
Synthesis and Preclinical Characterization of LY3154885, a Human Dopamine D1 Receptor Positive Allosteric Modulator with an Improved Nonclinical Drug-Drug Interaction Risk ProfileJunliang Hao, James Beck, Xin Zhou, et al.
Pageof 13